Report Categories Report Categories

Report Categories

industry Category

All

Total: 16 records, 2 pages

HuiJianTou lanJianTou

Global Low Molecular Weight Heparin Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Chemical & Material

new_biaoQian Low Molecular Weight Heparin

The global Low Molecular Weight Heparin market size is expected to reach $ 495.7 million by 2030, rising at a market growth of 5.2% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Chemical & Material

new_biaoQian Low Molecular Weight Heparin

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin market size was valued at USD 348.4 million in 2023 and is forecast to a readjusted size of USD 495.7 million by 2030 with a CAGR of 5.2% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin API Supply, Demand and Key Producers, 2024-2030

date 11 Oct 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin API

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.

USD4480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Oct 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin API

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.

USD3480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin Sodium Supply, Demand and Key Producers, 2024-2030

date 28 Feb 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Sodium

The global Low Molecular Weight Heparin Sodium market size is expected to reach $ 6154.7 million by 2030, rising at a market growth of 6.3% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Sodium

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin Sodium market size was valued at USD 4008.8 million in 2023 and is forecast to a readjusted size of USD 6154.7 million by 2030 with a CAGR of 6.3% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin (LMWHs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Chemical & Material

new_biaoQian Low Molecular Weight Heparin (LMWHs)

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin (LMWHs) market size was valued at USD 348.4 million in 2023 and is forecast to a readjusted size of USD 427.5 million by 2030 with a CAGR of 3.0% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin Injection Supply, Demand and Key Producers, 2024-2030

date 04 Jun 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD4480.00

Add To Cart

Add To Cart

Global Low Molecular Weight Heparin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jun 2024

date Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD3480.00

Add To Cart

Add To Cart

Global Ultra-low Molecular Weight Heparin (ULMWH) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 25 Jan 2024

date Pharma & Healthcare

new_biaoQian Ultra-low Molecular Weight Heparin (ULMWH)

According to our (Global Info Research) latest study, the global Ultra-low Molecular Weight Heparin (ULMWH) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Go To Page

Confirm

industry 09 Feb 2024

industry Chemical & Material

new_biaoQian Low Molecular Weight Heparin

The global Low Molecular Weight Heparin market size is expected to reach $ 495.7 million by 2030, rising at a market growth of 5.2% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Chemical & Material

new_biaoQian Low Molecular Weight Heparin

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin market size was valued at USD 348.4 million in 2023 and is forecast to a readjusted size of USD 495.7 million by 2030 with a CAGR of 5.2% during review period.

USD3480.00

addToCart

Add To Cart

industry 11 Oct 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin API

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.

USD4480.00

addToCart

Add To Cart

industry 11 Oct 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin API

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.

USD3480.00

addToCart

Add To Cart

industry 28 Feb 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Sodium

The global Low Molecular Weight Heparin Sodium market size is expected to reach $ 6154.7 million by 2030, rising at a market growth of 6.3% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Sodium

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin Sodium market size was valued at USD 4008.8 million in 2023 and is forecast to a readjusted size of USD 6154.7 million by 2030 with a CAGR of 6.3% during review period.

USD3480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Chemical & Material

new_biaoQian Low Molecular Weight Heparin (LMWHs)

According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin (LMWHs) market size was valued at USD 348.4 million in 2023 and is forecast to a readjusted size of USD 427.5 million by 2030 with a CAGR of 3.0% during review period.

USD3480.00

addToCart

Add To Cart

industry 04 Jun 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD4480.00

addToCart

Add To Cart

industry 04 Jun 2024

industry Pharma & Healthcare

new_biaoQian Low Molecular Weight Heparin Injection

Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

USD3480.00

addToCart

Add To Cart

industry 25 Jan 2024

industry Pharma & Healthcare

new_biaoQian Ultra-low Molecular Weight Heparin (ULMWH)

According to our (Global Info Research) latest study, the global Ultra-low Molecular Weight Heparin (ULMWH) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

Go To Page

Confirm